-
Loading metrics
HCV Viral Decline at Week 2 of Peg-IFN-Alpha-2a/RBV Therapy as a Predictive Tool for Tailoring Treatment in HIV/HCV Genotype 1 Co-Infected Patients
- Antonio Rivero-Juarez,
- Luis F. López-Cortés,
- Angela Camacho,
- Almudena Torres-Cornejo,
- Ana Gordon,
- Rosa Ruiz-Valderas,
- Julian Torre-Cisneros,
- Juan A. Pineda,
- Pompeyo Viciana,
- Antonio Rivero
x
- Published: June 19, 2014
- https://doi.org/10.1371/journal.pone.0099468